IceCure Medical (ICCM) Cost of Revenue (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Cost of Revenue data on file, last reported at $616000.0 in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 21.5% year-over-year to $616000.0 in Q1 2026; TTM through Mar 2026 was $2.3 million, a 20.77% increase from a year earlier, with the FY2025 full-year figure at $2.2 million, up 17.01% from the prior year.
• Cost of Revenue for Q1 2026 stood at $616000.0, down from $679000.0 in the prior quarter.
• Over the last five years, Cost of Revenue for ICCM reached as high as $679000.0 in Q4 2025 and fell as low as -$1.1 million in Q4 2023.
• Historically, Cost of Revenue has averaged $292764.7 across 5 years, with a median of $458000.0 in 2024.
• Across the five-year window, Cost of Revenue sank 158.82% in 2022 and soared 142.84% in 2024, its largest moves.
• Year by year, Cost of Revenue stood at -$968000.0 in 2022, then declined by 10.43% to -$1.1 million in 2023, then surged by 142.84% to $458000.0 in 2024, then jumped by 48.25% to $679000.0 in 2025, then fell by 9.28% to $616000.0 in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $616000.0 in Q1 2026, $679000.0 in Q4 2025, and $573000.0 in Q3 2025.